Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
hepatitis b
7
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
clinical trials
deals
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
alnylam pharmaceuticals
amgen
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
national
purdue pharma
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
abbvie
astrazeneca
biotech ipos
What
drug
medicines
bio
roundup
dicerna
disease
hepatitis
new
pharma
pipeline
research
way
abandoning
abbvie’s
acquisitions
adds
advantages
ago
alliance
areas
baggage
bar
barbecuing
biggest
biosciences
biotechs
bio’s
brii
brings
build
buy
camping
cardiologist
caught
causing
center
central
ceo
check
cholesterol
Language
unset
Current search:
" hepatitis b "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M